2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions

View by Date

Abstract Number: 2234

Can the Fracture Risk Assessment Tool (FRAX) Also Predict Falls in Older Women?
Abstract Number: 2235

Shocking? a Systematic Review of Adrenal Insufficiency in Adults on Oral Steroids
Abstract Number: 2236

Global Prevalence of Hyperuricemia: A Systematic Review of Population-Based Epidemiological Studies
Abstract Number: 2237

Effects of Coffee Consumption on Serum Uric Acid. a Systematic Review and Meta-Analysis
Abstract Number: 2238

Body Mass Index Modulates the Relationship Between Sugar-Sweetened Beverage Intake and Serum Urate Concentration
Abstract Number: 2239

Prevalence of Gout and Hyperuricemia and Association with Fat Mass and Fat Free Mass: Results from a Population-Based Study
Abstract Number: 2240

Effectiveness of Allopurinol in Achieving and Sustaining Target Serum Urate: A Study Using Large Intergrated National Health Network
Abstract Number: 2241

Treating to Target in Gout: The Epidemiology of Serum Urate Measurement Among Patients with Incident Gout in Usual Care Settings in the United States
Abstract Number: 2242

Compliance with Allopurinol Among Hypertensive Patients with Gout Diagnosis and the Relationship to Onset of End-Stage Renal Disease
Abstract Number: 2243

Economic Burden of Controlled Gout, Uncontrolled Gout, and Gout Exacerbated By Common Comorbidities: Results from the 2012-2013 National Health and Wellness Survey
Abstract Number: 2244

Risk of Incident Atrial Fibrillation in Gout
Abstract Number: 2245

Periarticular Bone Mineral Density Predicts Structural Progression of Knee Osteoarthritis Independently of Static Alignment
Abstract Number: 2246

Occupations Involving Manual Labor Increase the Risk for Incident Knee Osteoarthritis
Abstract Number: 2247

Health Care Practices and Care Consumption in a Population Based Cohort of Symptomatic Knee and/or Hip OA Patients
Abstract Number: 2248

Knee Pain Burden Is Associated with Decreased Motor Performance: Data from the Osteoarthritis Initiative

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].